BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 29053609)

  • 1. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of renal cell carcinoma: an update.
    Lopez-Beltran A; Cheng L; Vidal A; Scarpelli M; Kirkali Z; Blanca A; Montironi R
    Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):61-76. PubMed ID: 23700715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.
    Hes O; Compérat EM; Rioux-Leclercq N
    Ann Diagn Pathol; 2016 Apr; 21():59-64. PubMed ID: 26897641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 and 2 papillary renal cancers are genetically distinct.
    Balakrishnan VS
    Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathology of kidney tumors: introduction of the 2004 WHO classification].
    Zou WZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):517-9. PubMed ID: 17134542
    [No Abstract]   [Full Text] [Related]  

  • 9. Papillary Renal Cell Carcinoma (PRCC): An Update.
    Akhtar M; Al-Bozom IA; Al Hussain T
    Adv Anat Pathol; 2019 Mar; 26(2):124-132. PubMed ID: 30507616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].
    Moch H
    Pathologe; 2016 Mar; 37(2):127-33. PubMed ID: 26942728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
    Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
    Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects.
    Zhao M; He XL; Teng XD
    Diagn Pathol; 2015 Sep; 10():168. PubMed ID: 26377921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of renal cell cancer: pathology and genetics.
    Moch H
    Semin Cancer Biol; 2013 Feb; 23(1):3-9. PubMed ID: 22722066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma, unclassified with unique features.
    Chander B; Preet K; Bharti R; Deb P
    J Cancer Res Ther; 2015; 11(4):1027. PubMed ID: 26881600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The translocation carcinoma: A pediatric renal tumor also in adults].
    Bruder E; Moch H
    Pathologe; 2016 Mar; 37(2):159-65. PubMed ID: 26972595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.
    Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
    Adeniran AJ; Shuch B; Humphrey PA
    Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype.
    Papadopoulos EI; Petraki C; Gregorakis A; Fragoulis EG; Scorilas A
    Biol Chem; 2016 Jun; 397(6):529-39. PubMed ID: 26866880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.